ALCON AG

NYSE: ALC (Alcon Inc.)

最近更新时间: 02 Jan, 9:59PM

77.60

-1.21 (-1.54%)

前收盘价格 78.81
收盘价格 78.90
成交量 1,310,869
平均成交量 (3个月) 1,899,898
市值 38,263,422,976
市盈率 (P/E TTM) 37.67
预期市盈率 (P/E Forward) 23.20
价格/销量 (P/S) 3.86
股市价格/股市净资产 (P/B) 1.68
52周波幅
71.55 (-7%) — 99.20 (27%)
利润日期 11 Nov 2025
股息率 (DY TTM) 0.35%
营业毛利率 11.28%
营业利益率 (TTM) 13.30%
稀释每股收益 (EPS TTM) 2.25
季度收入增长率 (YOY) 0.60%
季度盈利增长率 (YOY) 41.10%
总债务/股东权益 (D/E MRQ) 23.63%
流动比率 (MRQ) 2.70
营业现金流 (OCF TTM) 2.12 B
杠杆自由现金流 (LFCF TTM) 1.18 B
资产报酬率 (ROA TTM) 2.74%
股东权益报酬率 (ROE TTM) 5.23%

市场趋势

短期 中期
行业 Medical Instruments & Supplies (US) 看涨 混合的
Medical Instruments & Supplies (全球的) 看涨 混合的
股票 Alcon Inc. 看跌 看跌

AIStockmoo 评分

0.8
分析师共识 -0.5
内部交易活动 NA
价格波动 3.5
技术平均移动指标 2.5
技术振荡指标 -2.5
平均 0.75

相关股票

股票 市值 DY P/E(TTM) P/B
ALC 38 B 0.35% 37.67 1.68
RMD 37 B 0.21% 25.71 6.18
STVN 5 B 0.21% 32.37 3.23
BDX 59 B 0.50% 35.43 2.32
WST 20 B 0.15% 41.01 6.12
BLCO 6 B - - 0.940

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

部门 Healthcare
行业 Medical Instruments & Supplies
投资方式 Large Core
内部持股比例 0.13%
机构持股比例 68.26%
52周波幅
71.55 (-7%) — 99.20 (27%)
目标价格波幅
75.00 (-3%) — 100.00 (28%)
100.00 (Mizuho, 28.87%) 购买
94.50 (21.78%)
75.00 (B of A Securities, -3.35%) 卖出
平均值 90.33 (16.41%)
总计 4 购买, 1 保留, 1 卖出
平均价格@调整类型 78.43
公司 日期 目标价格 调整类型 价格@调整类型
Stifel 09 Jan 2026 80.00 (3.09%) 保留 80.13
B of A Securities 11 Dec 2025 75.00 (-3.35%) 卖出 78.76
BTIG 24 Nov 2025 91.00 (17.27%) 购买 76.25
Baird 13 Nov 2025 98.00 (26.29%) 购买 78.61
Needham 12 Nov 2025 98.00 (26.29%) 购买 79.44
Mizuho 11 Nov 2025 100.00 (28.87%) 购买 77.36

该时间范围内无数据。

日期 类型 细节
06 Jan 2026 公告 Alcon Terminates Agreement to Acquire STAAR Surgical
06 Jan 2026 公告 Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon
30 Dec 2025 公告 Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
19 Dec 2025 公告 Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
19 Dec 2025 公告 Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
17 Dec 2025 公告 STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
17 Dec 2025 公告 Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
17 Dec 2025 公告 Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
16 Dec 2025 公告 Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
16 Dec 2025 公告 Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
12 Dec 2025 公告 Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon
11 Dec 2025 公告 STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
11 Dec 2025 公告 Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
10 Dec 2025 公告 Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
09 Dec 2025 公告 Alcon Announces Amended Merger Agreement with STAAR Surgical
09 Dec 2025 公告 Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical
08 Dec 2025 公告 Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process
08 Dec 2025 公告 Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
08 Dec 2025 公告 STAAR Surgical Announces Expiration of Go-Shop Period
02 Dec 2025 公告 Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
11 Nov 2025 公告 Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds
10 Nov 2025 公告 Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
07 Nov 2025 公告 STAAR Surgical Announces Amendments to Alcon Merger Agreement
04 Nov 2025 公告 Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders
04 Nov 2025 公告 Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
31 Oct 2025 公告 Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
27 Oct 2025 公告 STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
24 Oct 2025 公告 Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
24 Oct 2025 公告 Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
23 Oct 2025 公告 Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
显示更多
股息率 (DY TTM) 0.35%
5年平均股息收益率 0.20%
股息支付比率 11.81%
除息日 公告日期 支付日期 详情
14 May 2024 08 Apr 2024 16 May 2024 0.2644 现金
10 May 2023 30 Mar 2023 12 May 2023 0.2356 现金
29 Apr 2022 24 Mar 2022 05 May 2022 0.2083 现金
04 May 2021 24 Mar 2021 06 May 2021 0.0909 现金

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2024 0.264 1 0.31
2023 0.236 1 0.30
2022 0.208 1 0.30
2021 0.091 1 0.10

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票